抑制自增强了通过调节cGAS-STING通路来调节线性灾难介导的抗癌免疫反应
Zhaoshi Bai1, Yaling Peng2, Xue'er Xia2
1Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & the Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210009, China.
一种新的微管向剂,BZML,通过线粒体灾难诱导免疫细胞死亡,增强癌症免疫疗法. 抑制自会通过调节cGAS-STING通路来增强这些效应.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 免疫检查点抑制剂 (ICI) 在癌症治疗中存在局限性.
- 癌症免疫治疗需要新的治疗策略.
研究的目的:
- 为了研究BZML的抗癌活性,一个微管向剂.
- 探索线粒体灾难和cGAS-STING通路在BZML诱导的癌细胞死亡和免疫反应中的作用.
主要方法:
- 用BZML和其他化疗药物 (帕克利塔克塞尔,多塞塔克塞尔,多克索鲁比辛) 治疗癌细胞 (A549/Taxol,L929).
- 对线粒体灾难,核膜完整性,核酶活性和cGAS-STING通路激活的评估.
- 对细胞表面标记物 (CALR,MHC-I) 和HMGB1释放的分析.
- 评估CD8+T细胞介导的抗癌作用.
- 调查自抑制及其对cGAS-STING通路和免疫反应的影响.
主要成果:
- 由于BZML在癌细胞中引起了线粒式灾难,从而诱导了强大的抗癌活性.
- 引发cGAS-STING通路激活和免疫细胞死亡标志物 (CALR,MHC-I,HMGB1) 的原因是菌灾难,而不是细胞亡.
- 激活的CD8+ T细胞增强了BZML的抗癌作用,由线粒体灾难介导.
- 抑制cGAS-STING通路损害了线粒体灾难介导的免疫效应,但不是线粒体灾难本身.
- 自抑制逆转了p-TBK1的衰退,并促进了线粒体灾难介导的抗癌免疫效应.
结论:
- 通过诱导免疫细胞死亡,BZML是癌症免疫疗法的有希望的药物.
- 线粒体灾难是激活抗癌免疫反应的关键机制.
- 抑制自会通过调节cGAS-STING通路来增强化疗诱导的抗癌免疫力.
更多相关视频
09:10siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
Inhibition of Cdk Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Drugs that Stabilize Microtubules
